All
Research
Education
연구
교육
Business
솔루션
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
로그인
Faculty of Engineering and Natural Sciences,
Nanotechnology Research and Application Center
Murat Cokol has not added Biography.
If you are Murat Cokol and would like to personalize this page please email our Author Liaison for assistance.
Systematic exploration of synergistic drug pairs.
Molecular systems biology , 2011 | Pubmed ID: 22068327
Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α.
BMC cancer Oct, 2012 | Pubmed ID: 23033967
Drugs and their interactions.
Current drug discovery technologies Jun, 2013 | Pubmed ID: 23237673
Oxidative stress is a mediator for increased lipid accumulation in a newly isolated Dunaliella salina strain.
PloS one , 2014 | Pubmed ID: 24651514
Large-scale identification and analysis of suppressive drug interactions.
Chemistry & biology Apr, 2014 | Pubmed ID: 24704506
A drug similarity network for understanding drug mechanism of action.
Journal of bioinformatics and computational biology Apr, 2014 | Pubmed ID: 24712534
Strength of selection pressure is an important parameter contributing to the complexity of antibiotic resistance evolution.
Molecular biology and evolution Sep, 2014 | Pubmed ID: 24962091
Target-independent prediction of drug synergies using only drug lipophilicity.
Journal of chemical information and modeling Aug, 2014 | Pubmed ID: 25026390
Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives.
Drug discovery today Feb, 2016 | Pubmed ID: 26360051
Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.
Cancer discovery Nov, 2015 | Pubmed ID: 26482930
Chemogenomics and orthology-based design of antibiotic combination therapies.
Molecular systems biology 05, 2016 | Pubmed ID: 27222539
Temporal and intrinsic factors of rifampicin tolerance in mycobacteria.
Proceedings of the National Academy of Sciences of the United States of America 07, 2016 | Pubmed ID: 27357669
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.
OncoTargets and therapy , 2016 | Pubmed ID: 27877053
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Journal of medicinal chemistry May, 2017 | Pubmed ID: 28383902
Synthesis and characterization of amino acid-functionalized calcium phosphate nanoparticles for siRNA delivery.
Colloids and surfaces. B, Biointerfaces Oct, 2017 | Pubmed ID: 28689100
Efficient measurement and factorization of high-order drug interactions in .
Science advances Oct, 2017 | Pubmed ID: 29026882
Sabanci University
Harvard Medical School
Melike Cokol-Cakmak1,
Feray Bakan2,
Selim Cetiner1,
Murat Cokol1,2,3
1Faculty of Engineering and Natural Sciences, Sabanci University,
2Nanotechnology Research and Application Center, Sabanci University,
3Laboratory of Systems Pharmacology, Harvard Medical School
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
저자
사서
액세스
JoVE 소개
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. 판권 소유
당사 웹 사이트에서는 사용자의 경험을 향상시키기 위해 쿠키를 사용합니다.
당사 웹 사이트를 계속 사용하거나 '계속'을 클릭하는 것은 당사 쿠키 수락에 동의하는 것을 의미합니다.
더 알아보기